Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Biosimilars and Bioanalytical Methods, and Acute Lymphoblastic Leukemia research.
Phase II One Arm Multicenter Study of Early Reinfusion of Tisagenlecleucel to Promote Durable B-cell Aplasia in Pediatric and Young Adult Patients with relapsed/refractory CD19-Positive B-cell Acute Lymphoblastic Leukemia (REFUEL)
CAR T cell therapy for children with rheumatic disease: the time is now
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY
Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia
Mediport use as an acceptable standard for CAR T cell infusion
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia
Toxicity and management in CAR T-cell therapy